ACCESSION: MSBNK-SMB_Measured-HSA014P0267000
RECORD_TITLE: Annotated; Inosine; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 39
COMMENT: RAW_SPEC {'EL14-neg_2332': {'bp': 4595624.0, 'sum': 7328806.0}, 'EL19-neg_2319': {'bp': 3617929.0, 'sum': 6155091.0}, 'EL02-neg_2376': {'bp': 3234576.0, 'sum': 5279615.0}, 'EL15-neg_2355': {'bp': 2453111.0, 'sum': 3989431.0}, 'EL17-neg_2314': {'bp': 2111412.0, 'sum': 3474314.0}, 'EL18-neg_2352': {'bp': 1890079.0, 'sum': 3113774.0}, 'EL18-neg_2318': {'bp': 1871749.0, 'sum': 3253048.0}, 'EL17-neg_2348': {'bp': 1814650.0, 'sum': 2990541.0}, 'EL06-neg_2320': {'bp': 1786493.0, 'sum': 3107224.0}, 'EL01-neg_2340': {'bp': 1751844.0, 'sum': 2850389.0}, 'EL03-neg_2320': {'bp': 1600748.0, 'sum': 2593075.0}, 'EL08-neg_2310': {'bp': 1473434.0, 'sum': 2522591.0}, 'EL21-neg_2340': {'bp': 1472883.0, 'sum': 2430709.0}, 'EL22-neg_2349': {'bp': 1395110.0, 'sum': 2254972.0}, 'EL02-neg_2410': {'bp': 1364615.0, 'sum': 2172458.0}, 'EL13-neg_2380': {'bp': 1282024.0, 'sum': 2060060.0}, 'EL20-neg_2368': {'bp': 1094713.0, 'sum': 2251279.0}, 'EL13-neg_2346': {'bp': 848990.0, 'sum': 1439479.0}, 'EL04-neg_2305': {'bp': 814673.0, 'sum': 1364610.0}, 'EL15-neg_2389': {'bp': 768262.0, 'sum': 1244771.0}, 'EL12-neg_2340': {'bp': 707048.0, 'sum': 1153132.0}, 'EL19-neg_2353': {'bp': 662041.0, 'sum': 1065848.0}, 'EL10-neg_2380': {'bp': 550964.0, 'sum': 905230.0}, 'EL24-neg_2334': {'bp': 542563.0, 'sum': 1008784.0}, 'EL14-neg_2366': {'bp': 538696.0, 'sum': 873397.0}, 'EL05-neg_2348': {'bp': 448628.0, 'sum': 792481.0}, 'EL23-neg_2383': {'bp': 405585.0, 'sum': 778149.0}, 'EL20-neg_2402': {'bp': 326604.0, 'sum': 544450.0}, 'EL01-neg_2374': {'bp': 305148.0, 'sum': 505621.0}, 'EL09-neg_2337': {'bp': 285401.0, 'sum': 600287.0}, 'EL21-neg_2374': {'bp': 271946.0, 'sum': 473286.0}, 'EL07-neg_2317': {'bp': 265536.0, 'sum': 446886.0}, 'EL06-neg_2354': {'bp': 232270.0, 'sum': 383756.0}, 'EL11-neg_2340': {'bp': 227889.0, 'sum': 404888.0}, 'EL08-neg_2345': {'bp': 174405.0, 'sum': 304836.0}, 'EL16-neg_2364': {'bp': 133948.0, 'sum': 256921.0}, 'EL03-neg_2354': {'bp': 101668.0, 'sum': 180646.0}, 'EL04-neg_2339': {'bp': 95605.0, 'sum': 186387.0}, 'EL12-neg_2373': {'bp': 59933.0, 'sum': 139704.0}}
COMMENT: RETENTION_TIME_STDEV 0.042
COMMENT: PRECURSOR_M/Z_RAW 267.073486
COMMENT: PRECURSOR_M/Z_STDEV 0.000096
COMMENT: PRECURSOR_IN_MS1 mz 267.073522; int 105.175; delta(ppm) 1.399800
COMMENT: PROPOSED_CHARGE_STATE -1; mz 268.077213; int 11.812; cor 0.980
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Cl; mz 303.050152; int 2.808; cor 0.911
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.022; C10H12N4O5; [M-H]1; delta(ppm) -0.022381
COMMENT: PROPOSED_MF SevenGoldenRules 4.969; C9H16O9; [M-H]1; delta(ppm) 4.968652
COMMENT: PROPOSED_MF MS-FINDER 3.719; C10H12N4O5; [M-H]-; delta(ppm) -0.019060
COMMENT: PROPOSED_MF MS-FINDER 2.985; C9H16O9; [M-H]-; delta(ppm) 4.988627
COMMENT: PROPOSED_MF MS-FINDER 2.838; C10H20O4S2; [M-H]-; delta(ppm) 1.734754
COMMENT: PROPOSED_MF MS-FINDER 2.593; C11H16N4S2; [M-H]-; delta(ppm) -3.272902
COMMENT: PROPOSED_MF MS-FINDER 2.074; C4H13N8O4P; [M-H]-; delta(ppm) 3.850902
COMMENT: PROPOSED_MF SIRIUS5_Sirius 14.462; C9H16O9; [M-H]-; delta(ppm) 4.988627
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.922; C10H12N4O5; [M-H]-; delta(ppm) -0.019060
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.650; C8H17N2O6P; [M-H]-; delta(ppm) -6.203712
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.983; C10H20O4S2; [M-H]-; delta(ppm) 1.734754
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.261; C11H16N4S2; [M-H]-; delta(ppm) -3.272902
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.351; C13H11F3N2O; [M-H]-; delta(ppm) -5.925509
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.333; C14H21Br; [M-H]-; delta(ppm) -7.103755
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.679; C14H12N4S; [M-H]-; delta(ppm) 9.349647
COMMENT: PROPOSED_MF SIRIUS5_Sirius -2.451; C13H17ClN2S; [M-H]-; delta(ppm) -82451.302160
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.837; C10H12N4O5; [M-H]-; delta(ppm) -0.019060
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.163; C9H16O9; [M-H]-; delta(ppm) 4.988627
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.913; C10H12N4O5; [M-H]-; delta(ppm) -0.019060
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.657; C9H16O9; [M-H]-; delta(ppm) 4.988627
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.218; C11H8N8O; [M-H]-; delta(ppm) -5.026698
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.619; C7H13FN4O6; [M-H]-; delta(ppm) -4.297467
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.270; C8H17N2O6P; [M-H]-; delta(ppm) -6.203712
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.697; C8H11F7N2; [M-H]-; delta(ppm) -1.048152
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.276; C11H13FN4OS; [M-H]-; delta(ppm) 5.071160
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.732; C8H9FN8O2; [M-H]-; delta(ppm) -9.305062
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.479; C9H16N4O2Si2; [M-H]-; delta(ppm) -193175.447271
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.257; C8H11F3N4O3; [M-H]-; delta(ppm) 9.136840
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.577; C11H8N8O; [M-H]-; delta(ppm) -5.026698
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.421; C10H12N4O5; [M-H]-; delta(ppm) -0.019060
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C11H13FN4OS; [M-H]-; delta(ppm) 5.071160
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C8H9FN8O2; [M-H]-; delta(ppm) -9.305062
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C9H16N4O2Si2; [M-H]-; delta(ppm) -193175.447271
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C8H11F3N4O3; [M-H]-; delta(ppm) 9.136840
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 31.000; UGQMRVRMYYASKQ-KQYNXXCUSA-N; C10H12N4O5; 4687 - 40.0 eV
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 7.000; UGQMRVRMYYASKQ-UHFFFAOYSA-N; C10H12N4O5; inosine CollisionEnergy:205060
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.152; PFUVWXNGEZZGDC-XWQRRUDANA-N; [M-H]-; OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC(=O)N=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.974; UKUBRHKAZHFGHP-YPLCUDRINA-N; [M-H]-; O[C@@H]1CO[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.952; UGQMRVRMYYASKQ-KQYNXXCUSA-N; [M-H]-; OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC=NC2=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.946; MDWFCNXLWFANLX-UHFFFAOYSA-N; [M-H]-; N#CC1=CN(C(=O)N=C1N)C2OC(CO)C(O)C2O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.841; MTCJZZBQNCXKAP-MXWFMQRVNA-N; [M-H]-; OC[C@H]1O[C@H](C(O)[C@H]1O)C1=NNC2=C1NC=NC2=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.384; UGQMRVRMYYASKQ-KQYNXXCUSA-N; [M-H]-; Inosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.743; KFQUAMTWOJHPEJ-DAGMQNCNSA-N; [M-H]-; Allopurinol riboside
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.652; MTCJZZBQNCXKAP-MXWFMQRVNA-N; [M-H]-; Formycin B;Laurusin;NSC 106486;Ohyamycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.495; PFUVWXNGEZZGDC-XWQRRUDANA-N; [M-H]-; C00050742
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.476; UKUBRHKAZHFGHP-YPLCUDRINA-N; [M-H]-; UNPD117399
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.418; UKNHQPDCWMADJW-UHFFFAOYNA-N; [M-H]-; Allopurinol riboside
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.418; HGCFOIQIZGBTIS-UHFFFAOYSA-N; [M-H]-; 1-(3,5-dinitrophenyl)-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.418; XDQRHMCJMFDNHH-UHFFFAOYSA-N; [M-H]-; 1-(3,5-dinitrophenyl)-3-propylurea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.395; MDWFCNXLWFANLX-UHFFFAOYSA-N; [M-H]-; 4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidine-5-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.391; HVWJXIVKNISITK-UHFFFAOYSA-N; [M-H]-; 9-[3,4-bis(hydroxymethyl)oxetan-2-yl]-9H-purine-2,6-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.378; VSYDQMYGYZGSMT-ZCJUSREXSA-N; [M-H]-; 2-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.368; CMWAWVXQXJHWLC-UHFFFAOYSA-N; [M-H]-; 7-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.368; GSBZMZQCPPJDRM-UHFFFAOYSA-N; [M-H]-; N'-(2,4-dinitrophenyl)butanehydrazide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.154; DDXCFDOPXBPUJC-SAYMMRJXSA-N; [M-H]-; 2-(alpha-D-mannosyl)-D-glyceric acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.107; CLRLHXKNIYJWAW-QBTAGHCHSA-N; [M-H]-; deaminoneuraminic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.913; RKFYTTOYCOWKNS-HRGURGDMNA-N; [M-H]-; UNPD171600
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.835; ZMDXTLMYXHWJFS-VXZGBONXSA-N; [M-H]-; [(3S,4R,5S,6S)-3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.835; MIZSCWXOEGHXSU-QPRHPKICSA-N; [M-H]-; [(3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.831; YGZRIKTWJWNZEX-XHQAPYKUSA-N; [M-H]-; 2-[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.786; FQHUAUMYHAJTDH-OBGYXPEHNA-N; [M-H]-; 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.621; VDKGMDBOKWTGOX-XIQGVFHDSA-N; [M-H]-; (6S,7R,8R)-2,4,6,7,8,9-hexahydroxy-5-oxononanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.514; VMVLDMNHEFLYGL-BWNVTPFRNA-N; [M-H]-; UNPD23911
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.156; HNVKQXJBINMTGG-UHFFFAOYSA-N; [M-H]-; 1-ethyl-3-[[[(phenylmethyl)amino]-sulfanylidenemethyl]amino]thiourea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MDWFCNXLWFANLX-UHFFFAOYSA-N; [M-H]-; 4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidine-5-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RKFYTTOYCOWKNS-HRGURGDMNA-N; [M-H]-; UNPD171600
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.974; UGQMRVRMYYASKQ-KQYNXXCUSA-N; [M-H]-; Inosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.974; PFUVWXNGEZZGDC-XWQRRUDANA-N; [M-H]-; C00050742
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.954; UKNHQPDCWMADJW-UHFFFAOYNA-N; [M-H]-; Allopurinol riboside
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.945; UKUBRHKAZHFGHP-YPLCUDRINA-N; [M-H]-; UNPD117399
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.944; KFQUAMTWOJHPEJ-DAGMQNCNSA-N; [M-H]-; Allopurinol riboside
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.937; MTCJZZBQNCXKAP-MXWFMQRVNA-N; [M-H]-; Formycin B;Laurusin;NSC 106486;Ohyamycin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.924; VSYDQMYGYZGSMT-ZCJUSREXSA-N; [M-H]-; 2-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.788; GSBZMZQCPPJDRM-UHFFFAOYSA-N; [M-H]-; N'-(2,4-dinitrophenyl)butanehydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.739; ZMDXTLMYXHWJFS-VXZGBONXSA-N; [M-H]-; [(3S,4R,5S,6S)-3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.689; YGZRIKTWJWNZEX-XHQAPYKUSA-N; [M-H]-; 2-[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.679; MIZSCWXOEGHXSU-QPRHPKICSA-N; [M-H]-; [(3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.679; DDXCFDOPXBPUJC-SAYMMRJXSA-N; [M-H]-; 2-(alpha-D-mannosyl)-D-glyceric acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.675; HGCFOIQIZGBTIS-UHFFFAOYSA-N; [M-H]-; 1-(3,5-dinitrophenyl)-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.675; XDQRHMCJMFDNHH-UHFFFAOYSA-N; [M-H]-; 1-(3,5-dinitrophenyl)-3-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.666; CMWAWVXQXJHWLC-UHFFFAOYSA-N; [M-H]-; 7-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.635; HVWJXIVKNISITK-UHFFFAOYSA-N; [M-H]-; 9-[3,4-bis(hydroxymethyl)oxetan-2-yl]-9H-purine-2,6-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.598; CLRLHXKNIYJWAW-QBTAGHCHSA-N; [M-H]-; deaminoneuraminic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FQHUAUMYHAJTDH-OBGYXPEHNA-N; [M-H]-; 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VDKGMDBOKWTGOX-XIQGVFHDSA-N; [M-H]-; (6S,7R,8R)-2,4,6,7,8,9-hexahydroxy-5-oxononanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; UGQMRVRMYYASKQ-KQYNXXCUSA-N; [M-H]-; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.641; DDXCFDOPXBPUJC-WEDYNZIRSA-N; [M-H]-; 3-hydroxy-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.184; FQHUAUMYHAJTDH-IMSDGWMTSA-N; [M-H]-; (4S,5R,6R,7R,8S)-4,5,6,7,8,9-hexahydroxy-2-oxononanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.880; CLRLHXKNIYJWAW-YOQZMRDMSA-N; [M-H]-; (2S,4S,5R,6R)-2,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.230; MTCJZZBQNCXKAP-KSYZLYKTSA-N; [M-H]-; 3-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.228; KFQUAMTWOJHPEJ-DAGMQNCNSA-N; [M-H]-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5H-pyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; NVAUCWNDTOEUTI-YRNVUSSQSA-N; [M-H]-; N-[(E)-(5-nitrofuran-2-yl)methylideneamino]morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.846; MOFOCQGMDMRUPN-RRKCRQDMSA-N; [M-H]-; 7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrazolo[3,4-d]pyrimidine-4,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; UCWVZJPSZVFVJG-RRKCRQDMSA-N; [M-H]-; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-pyrazolo[3,4-d]pyrimidine-4,6-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.683; UGQMRVRMYYASKQ; [M-H]-; Inosinum
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -34.770; ZZHJEOWCHAELGO; [M-H]-; 3-Isoinosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -43.555; MTBCDJLBNPJBFZ; [M-H]-; 7-beta-Ribofuranosylhypoxanthine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.778; UKUBRHKAZHFGHP; [M-H]-; 9-pentopyranosyl-3,9-dihydro-6h-purin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.253; NQAZHXBSLFDVKM; [M-H]-; 2''-Deoxyxanthosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.765; WOAUMMAKPRPVRY; [M-H]-; Inosine, 2''-deoxy-7,8-dihydro-8-oxo-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.224; KFQUAMTWOJHPEJ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.292; PFUVWXNGEZZGDC; [M-H]-; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.432; VKYHXDQOZGKJIN; [M-H]-; ACMC-20mqjn
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.072; QCYSYEMPACIOOP; [M-H]-; 2''-Deoxyoxanosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.038; HVWJXIVKNISITK; [M-H]-; ACMC-20mhqm
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.029; MTCJZZBQNCXKAP; [M-H]-; Laurusin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.257; MDWFCNXLWFANLX; [M-H]-; Oprea1_571258
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -420.280; XDQRHMCJMFDNHH; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -431.808; GSBZMZQCPPJDRM; [M-H]-; N''-(2,4-dinitrophenyl)butanehydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -443.011; HGCFOIQIZGBTIS; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -606.508; NVAUCWNDTOEUTI; [M-H]-; 4-Morpholinecarboxylic acid, (5-nitrofurfurylidine)hydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.459; UGQMRVRMYYASKQ; [M-H]-; Inosinum
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Inosine, UGQMRVRMYYASKQ-KQYNXXCUSA-N; Matching to 31 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (3), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000195;HMDB0003040;
CH$NAME: Inosine
CH$NAME: 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H12N4O5
CH$EXACT_MASS: 268.080769
CH$SMILES: C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
CH$IUPAC: InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1
CH$LINK: CHEBI CHEBI:17596
CH$LINK: HMDB HMDB0000195
CH$LINK: INCHIKEY UGQMRVRMYYASKQ-KQYNXXCUSA-N
CH$LINK: PUBCHEM CID:6021
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.019
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 267.073488
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-0930000000-a9da6f725332a62149fa
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  92.0239880 62.1356 92.023990 0.7824 7.72 0.9832 39 ?
  108.0189148 33.7831 108.018940 1.2035 5.65 0.9895 38 ?
  126.0295406 19.5925 126.029600 1.0712 3.72 0.9594 35 ?
  135.0299803 999.0000 135.030060 0.4592 0.00 0.9941 39 f{C5H3N4O1}/-9.29ppm,p-C5H8O4
  136.0342079 44.5607 136.034290 1.1027 3.89 0.9925 36 ?
  267.0733623 354.4840 267.073700 0.4119 32.84 1.0000 39 f{C10H11N4O5}/-0.49ppm,p
  268.0764409 39.5512 268.076780 1.1527 3.36 0.9954 34 ?
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  92.023988 62.14 62
  108.018915 33.78 33
  126.029541 19.59 19
  135.029980 999.00 999
  136.034208 44.56 44
  267.073362 354.48 354
  268.076441 39.55 39
//
